Collaborate Forward

Bridge the Technology Gaps: How Advarra Strengthens Site–Sponsor Collaboration

By |2026-03-04T10:03:03-05:00March 2nd, 2026|Collaborate Forward|

Understanding Today’s Collaboration Challenges One of the biggest barriers to effective study collaboration is the disconnect in how sponsors, CROs, and sites think about technology. According to Ashley Davidson, VP and Product Lead for Sponsor Tech Solutions at Advarra, this gap appears in nearly every early customer conversation. Continue Reading Article

Elevating the Site Voice through Action, Accountability, and Design

By |2026-02-16T15:20:40-05:00February 23rd, 2026|Collaborate Forward|

Medidata’s Site Insights Program reflects a deliberate shift toward transparency, efficiency, and true site-centricity in clinical research. Built on the belief that better technology starts with better listening, the program embeds the site voice into product design, training, and strategy. Every insight gathered is tied to action, ensuring that collaboration leads to measurable improvements

Strengthening Site Partnerships: Through Trust, Transparency, and Tailored Solutions

By |2026-02-13T11:51:46-05:00February 13th, 2026|Collaborate Forward|

Merck’s approach to site partnerships has evolved in response to two key drivers: the growing complexity of clinical trials and the need to foster meaningful, sustainable collaborations with sites. What began as a traditional sponsor-led relationship has transformed into a collaborative model centered on core principles—communication, flexibility, transparency, and shared values. Continue Reading Article

Collaboration in Practice: How Alcanza Leads With Principles to Drive Human-Centered Change

By |2026-02-13T12:20:22-05:00December 8th, 2025|Collaborate Forward|

As the clinical research industry continues evolving at a rapid pace, organizations are increasingly recognizing that meaningful progress happens when people lead with intention, humility, and openness. For Carlos Orantes, Chief Executive Officer, and Casey Orvin, Chief Commercial Officer, collaboration is not a strategy — it is a reflection of who Alcanza is. Guided

Collaboration Redefined: Parexel’s Site Alliance Partnership and Accountability

By |2026-02-13T16:12:50-05:00December 4th, 2025|Collaborate Forward|

Through its Site Alliance evolution, Parexel demonstrates how a CRO can redefine accountability, foster transparency, and elevate site relationships. By adapting to sites’ changing needs, creating clear points of contact, and investing in emerging sites through curated efforts and mentoring programs, Parexel continues to advance a collaborative culture where sites feel heard, supported, and

Collaboration by Design: How ProofPilot Is Building Connection Into Every Study

By |2026-02-13T16:17:29-05:00November 4th, 2025|Collaborate Forward|

In clinical research, collaboration can’t be an afterthought. It must be built into the process, from the first site contact to the last database lock. ProofPilot is proving what happens when that principle is taken seriously: collaboration by design. Built for Collaboration, Not Just Study Execution ProofPilot’s platform isn’t just another study management

Founding Vision & Philosophy: A People-First Approach

By |2026-02-13T16:18:28-05:00September 23rd, 2025|Collaborate Forward|

Mural Health is redefining patient and site support in clinical research by putting people first—employees, patients, and sites—and using structured, transparent feedback loops to continuously improve. By combining empathy and data to improve the clinical trial experience for patients, sites, and sponsors alike, Mural Health is helping all stakeholders build trust and make smarter

Serving Patients by Serving the Sites: Takeda Puts Patients and Sites at the Center

By |2026-02-13T16:20:55-05:00September 18th, 2025|Collaborate Forward|

For Takeda, evolving the way they work with clinical research sites wasn’t optional — it was essential. The company recognized that relying too heavily on outsourcing was damaging their relationship with sites, slowing progress, and limiting their ability to deliver treatments to patients faster. The answer was clear: take greater accountability for their own

Simplify, Support, Scale: GSK’s Blueprint for a Better Clinical Study Start-Up

By |2026-02-13T16:22:27-05:00August 26th, 2025|Collaborate Forward|

In clinical research, simplification isn’t a luxury. It’s a necessity. At GSK, that guiding principle is redefining their approach to study start-up, site engagement, and operational systems. Through bold investments in technology, including automation, and a clear focus on reducing site burden, GSK is working to turn administrative obstacles into opportunities for connection and

From Site Data to Site Advocacy: How the PPD™ Clinical Research Business Is Strengthening Relationships Through Transparency and Recognition

By |2025-07-31T13:34:33-04:00July 31st, 2025|Collaborate Forward|

In clinical research, strong relationships between CROs and clinical sites are built on more than just well-designed protocols. They require mutual understanding, proactive communication, and systems that reinforce trust. That’s where the PPD™ clinical research business of Thermo Fisher Scientific’s Strategic Site Collaborations (SSC) team steps in. As part of our Collaborate Forward

Go to Top